Skip to content

AKSA PHARMA

Active Private limited companyfounded 2016active for 10 yearsAraucarialaan 79, 1020 BrusselsKBO/BCE: BE 0651.787.243

Timeline

18 events since 2016

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBfull format · 61 days late
Annual accounts 2024 filed PDFfull format · 327 days late
2025
Weakest financial year net -€220,750 The net result drops to -€220,750, the lowest from 2017 to 2025.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0651787243
Registered office moved to BrusselsNew registered office: Avenue de l'Araucaria 79, 1020 Bruxelles · Previous registered office: ROULEVARD DE LA WOLUWE 70/141 point ▸
  • Registered-office move, Avenue de l'Araucaria 79, 1020 Bruxelles
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

2024
Annual accounts 2023 filed PDFfull format · 32 days late
2023
Equity above €200,000 equity €210,674 ▲275% After 3 profitable years in a row, equity reaches €210,674.
Change of role: BONTEMPS Richard, from manager to directorDirector discharge: BONTEMPS Richard5 points ▸
  • 1,860 shares
  • Power of attorney, Pamela CARRETTE
  • Director resignation, BONTEMPS Richard (manager)
  • Director appointment, BONTEMPS Richard (director (not named in the articles))
  • Director discharge, BONTEMPS Richard
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFfull format · 36 days late
2022
Highest result from 2017 to 2025 net €168,430 ▲127% The net result of €168,430 is the highest of those years.
Annual accounts 2021 filed PDFmicro format · 45 days late
2021
Back to profit net €74,271 The net result is €74,271, after 4 loss-making years.
Annual accounts 2020 filed PDFmicro format · 51 days late
2020
Annual accounts 2019 filed PDFmicro format · 119 days late
2019
Annual accounts 2018 filed PDFmicro format · 7 days late
2018
Annual accounts 2017 filed PDFmicro format · 34 days before the deadline
2016
First establishment Woluwedal 70, Woluwe-Saint-Lambert
Incorporation PDFpublished on 13-04-2016

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

AKSA PHARMA was incorporated on 11 April 2016.1 The registered office was moved to Brussels in 2025.2 Total assets rose from €40,302 in 2018 to €293,776 in 2025 and headcount from 1 to 1.6 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 03-11-2025
  3. 3National Bank, annual accounts 2018 and 2025

Next steps